2023 Q3 Form 10-Q Financial Statement

#000032012123000046 Filed on August 09, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2 2022 Q2
Revenue $36.19M $32.91M $55.79M
YoY Change -43.1% -41.01% 4.0%
Cost Of Revenue $23.17M $20.55M $34.86M
YoY Change -45.66% -41.05% 8.94%
Gross Profit $13.01M $12.36M $20.93M
YoY Change -37.87% -40.95% -3.29%
Gross Profit Margin 35.96% 37.55% 37.51%
Selling, General & Admin $22.71M $21.83M $28.61M
YoY Change -20.65% -23.7% -28.49%
% of Gross Profit 174.49% 176.6% 136.68%
Research & Development $3.154M $2.646M $4.489M
YoY Change -20.77% -41.06% -15.73%
% of Gross Profit 24.24% 21.41% 21.45%
Depreciation & Amortization $3.220M $1.696M $1.505M
YoY Change 436.67% 12.69% 7.19%
% of Gross Profit 24.74% 13.72% 7.19%
Operating Expenses $25.86M $24.47M $33.09M
YoY Change -20.66% -26.06% -26.99%
Operating Profit -$9.693M -$9.467M -$12.17M
YoY Change 26.39% -22.18% -30.36%
Interest Expense $178.0K $184.0K -$187.0K
YoY Change -1.66% -198.4% -197.4%
% of Operating Profit
Other Income/Expense, Net $1.222M $1.649M $118.0K
YoY Change 135.91% 1297.46% 268.75%
Pretax Income -$8.649M -$8.002M -$12.24M
YoY Change 17.96% -34.6% -30.61%
Income Tax $23.00K $22.00K $54.00K
% Of Pretax Income
Net Earnings -$8.672M -$8.024M -$12.29M
YoY Change 18.15% -34.71% -30.35%
Net Earnings / Revenue -23.97% -24.38% -22.03%
Basic Earnings Per Share -$0.12 -$0.12 -$0.21
Diluted Earnings Per Share -$0.12 -$0.12 -$181.1K
COMMON SHARES
Basic Shares Outstanding 69.58M shares 69.39M shares 67.88M shares
Diluted Shares Outstanding 69.57M shares 69.42M shares 67.88M shares

Balance Sheet

Concept 2023 Q3 2023 Q2 2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $100.0M $103.4M $122.6M
YoY Change -20.21% -15.61% -6.42%
Cash & Equivalents $99.95M $103.4M $122.6M
Short-Term Investments
Other Short-Term Assets $1.750M $1.850M $7.725M
YoY Change 88.17% -76.05% 916.45%
Inventory $984.0K $1.767M $3.630M
Prepaid Expenses $8.102M $7.321M
Receivables $25.42M $34.29M $50.68M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $136.2M $148.7M $184.6M
YoY Change -27.54% -19.47% 2.86%
LONG-TERM ASSETS
Property, Plant & Equipment $3.390M $3.842M $14.58M
YoY Change -33.89% -73.65% -41.02%
Goodwill $17.90M $17.90M
YoY Change 0.0%
Intangibles $38.98M $37.81M
YoY Change 45.15%
Long-Term Investments
YoY Change
Other Assets $1.038M $1.059M $1.052M
YoY Change 14.32% 0.67% 19.27%
Total Long-Term Assets $68.53M $68.19M $57.34M
YoY Change 15.34% 18.92% 37.53%
TOTAL ASSETS
Total Short-Term Assets $136.2M $148.7M $184.6M
Total Long-Term Assets $68.53M $68.19M $57.34M
Total Assets $204.7M $216.9M $242.0M
YoY Change -17.24% -10.37% 9.39%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.761M $11.99M $15.93M
YoY Change -83.1% -24.76% -10.51%
Accrued Expenses $4.696M $4.521M $29.21M
YoY Change -76.37% -84.52% 812.91%
Deferred Revenue $5.775M $6.138M
YoY Change -16.93%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $1.700M $1.660M $1.525M
YoY Change 9.11% 8.85% 9.01%
Total Short-Term Liabilities $29.58M $37.83M $54.20M
YoY Change -48.47% -30.2% 40.2%
LONG-TERM LIABILITIES
Long-Term Debt $10.00M $10.41M $12.07M
YoY Change -14.24% -13.76% -11.22%
Other Long-Term Liabilities $309.0K $303.0K $632.0K
YoY Change -29.13% -52.06% -65.52%
Total Long-Term Liabilities $309.0K $303.0K $12.70M
YoY Change -29.13% -97.61% 592.74%
TOTAL LIABILITIES
Total Short-Term Liabilities $29.58M $37.83M $54.20M
Total Long-Term Liabilities $309.0K $303.0K $12.70M
Total Liabilities $40.72M $49.32M $67.65M
YoY Change -42.14% -27.09% 22.12%
SHAREHOLDERS EQUITY
Retained Earnings -$267.8M -$259.2M -$217.8M
YoY Change 20.88% 19.02% 23.54%
Common Stock $431.9M $426.8M $392.0M
YoY Change 8.34% 8.88% 14.6%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $164.0M $167.5M $174.3M
YoY Change
Total Liabilities & Shareholders Equity $204.7M $216.9M $242.0M
YoY Change -17.24% -10.37% 9.39%

Cashflow Statement

Concept 2023 Q3 2023 Q2 2022 Q2
OPERATING ACTIVITIES
Net Income -$8.672M -$8.024M -$12.29M
YoY Change 18.15% -34.71% -30.35%
Depreciation, Depletion And Amortization $3.220M $1.696M $1.505M
YoY Change 436.67% 12.69% 7.19%
Cash From Operating Activities $840.0K -$4.113M $7.883M
YoY Change -92.99% -152.18% 32.13%
INVESTING ACTIVITIES
Capital Expenditures $3.840M $4.445M -$2.434M
YoY Change -206.08% -282.62% 16.85%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$3.840M -$3.881M -$2.434M
YoY Change 6.08% 59.45% 16.85%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -490.0K -1.020M -2.962M
YoY Change -91.28% -65.56% -108.88%
NET CHANGE
Cash From Operating Activities 840.0K -4.113M 7.883M
Cash From Investing Activities -3.840M -3.881M -2.434M
Cash From Financing Activities -490.0K -1.020M -2.962M
Net Change In Cash -3.490M -9.014M 2.487M
YoY Change -227.19% -462.44% -93.32%
FREE CASH FLOW
Cash From Operating Activities $840.0K -$4.113M $7.883M
Capital Expenditures $3.840M $4.445M -$2.434M
Free Cash Flow -$3.000M -$8.558M $10.32M
YoY Change -119.22% -182.95% 28.18%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
4145000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
130000 usd
CY2022Q2 us-gaap Interest Expense
InterestExpense
187000 usd
us-gaap Interest Expense
InterestExpense
433000 usd
us-gaap Interest Expense
InterestExpense
377000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-30650000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
45000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
125000 usd
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
67717000 shares
CY2023Q2 tls Other Financing Obligations Current
OtherFinancingObligationsCurrent
0 usd
CY2023Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
CY2023Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
20552000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
66151000 usd
CY2022Q2 us-gaap Gross Profit
GrossProfit
20929000 usd
us-gaap Gross Profit
GrossProfit
25841000 usd
us-gaap Gross Profit
GrossProfit
39800000 usd
CY2023Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1793000 usd
CY2022Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
4741000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
3436000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
9993000 usd
CY2023Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
21826000 usd
CY2022Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
34965000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
48278000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
70203000 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-9467000 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-14036000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-22437000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-30403000 usd
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1649000 usd
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
118000 usd
CY2023Q2 us-gaap Interest Expense
InterestExpense
184000 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-8002000 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-14105000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-18725000 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
22000 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
54000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-8024000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-14159000 usd
us-gaap Net Income Loss
NetIncomeLoss
-18770000 usd
us-gaap Net Income Loss
NetIncomeLoss
-30775000 usd
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.12
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.21
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.27
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.45
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.12
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.21
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.27
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.45
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
69424000 shares
CY2022Q4 tls Other Financing Obligations Current
OtherFinancingObligationsCurrent
1247000 usd
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
67876000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
68804000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
67717000 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
69424000 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
67876000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
68804000 shares
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-8024000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-14159000 usd
us-gaap Net Income Loss
NetIncomeLoss
-18770000 usd
us-gaap Net Income Loss
NetIncomeLoss
-30775000 usd
CY2023Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-11000 usd
CY2022Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-11000 usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
2000 usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
18000 usd
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-8035000 usd
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-14170000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-18768000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-30757000 usd
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
103447000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
119305000 usd
CY2023Q2 us-gaap Receivables Net Current
ReceivablesNetCurrent
34290000 usd
CY2022Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
40069000 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
1767000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
2877000 usd
CY2023Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
7321000 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
4819000 usd
CY2023Q2 us-gaap Other Assets Current
OtherAssetsCurrent
1850000 usd
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
893000 usd
CY2023Q2 us-gaap Assets Current
AssetsCurrent
148675000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
167963000 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3842000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4787000 usd
CY2023Q2 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
7222000 usd
CY2022Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
7832000 usd
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
326000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
341000 usd
CY2023Q2 us-gaap Goodwill
Goodwill
17922000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
17922000 usd
CY2023Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
37814000 usd
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
37415000 usd
CY2023Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1059000 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1137000 usd
CY2023Q2 us-gaap Assets
Assets
216860000 usd
CY2022Q4 us-gaap Assets
Assets
237397000 usd
CY2023Q2 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
16506000 usd
CY2022Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
22551000 usd
CY2023Q2 us-gaap Deferred Compensation Liability Current
DeferredCompensationLiabilityCurrent
9862000 usd
CY2022Q4 us-gaap Deferred Compensation Liability Current
DeferredCompensationLiabilityCurrent
8388000 usd
CY2023Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
6138000 usd
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
6444000 usd
CY2023Q2 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
1660000 usd
CY2022Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
1592000 usd
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
350000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
361000 usd
CY2023Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
3317000 usd
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
4919000 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
37833000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
45502000 usd
CY2023Q2 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
10406000 usd
CY2022Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
11248000 usd
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
0 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
27000 usd
CY2023Q2 tls Other Financing Obligations Noncurrent
OtherFinancingObligationsNoncurrent
0 usd
CY2022Q4 tls Other Financing Obligations Noncurrent
OtherFinancingObligationsNoncurrent
7211000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
270000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
641000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-8468000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-5775000 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
775000 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
710000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1584000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
2886000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
139000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
2603000 usd
tls Payment Of Dft Holdback Amount
PaymentOfDFTHoldbackAmount
564000 usd
tls Payment Of Dft Holdback Amount
PaymentOfDFTHoldbackAmount
0 usd
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
114000 usd
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-3176000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-6199000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-15857000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-3842000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
119438000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
126562000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
103581000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
122720000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
169895000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-8024000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-11000 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5676000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
167536000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-14159000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-11000 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
16423000 usd
CY2022Q2 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
3002000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
174312000 usd
us-gaap Net Income Loss
NetIncomeLoss
-18770000 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
2000 usd
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1942000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
167536000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
180254000 usd
us-gaap Net Income Loss
NetIncomeLoss
-30775000 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
18000 usd
us-gaap Restricted Stock Value Shares Issued Net Of Tax Withholdings
RestrictedStockValueSharesIssuedNetOfTaxWithholdings
-2886000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
30703000 usd
us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
3002000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
174312000 usd
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
Basis of Comparison - Revision of Previously Issued Interim Financial StatementsDuring the course of preparing the Company's consolidated financial statements for the year ended December 31, 2022, we identified that stock-based compensation expense related to performance-based restricted stock unit (“PSU”) awards with market conditions was erroneously reversed when those PSUs were forfeited during the three and six months ended June 30, 2022. Although the Company has determined that the error did not have a material impact on its previously issued interim consolidated financial statements, it revised the previously reported interim financial information in conjunction with the issuance of its quarterly filings on Form 10-Q for the quarter ended June 30, 2023.
us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-bottom:9pt;margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Preparing unaudited consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of revenue, expenses, assets and liabilities, and disclosure of contingent assets and liabilities. The Company regularly assesses these estimates; however, actual results could differ from those estimates. We base our estimates on historical experience, currently available information, and various other assumptions that we believe are reasonable under the circumstances.</span></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management evaluates these estimates and assumptions on an ongoing basis, including those relating to revenue recognition on cost estimation on certain contracts, allowance for credit losses, inventory obsolescence, valuation allowance for deferred tax assets, income taxes, certain assumptions related to stock-based compensation, valuation of intangible assets and goodwill, restructuring expenses accruals, and contingencies. Actual results could differ from those estimates. The impact of changes in estimates is recorded in the period in which they become known.</span></div>
CY2022Q4 us-gaap Restructuring Reserve
RestructuringReserve
2763000 usd
us-gaap Restructuring Reserve Accrual Adjustment1
RestructuringReserveAccrualAdjustment1
1197000 usd
us-gaap Payments For Restructuring
PaymentsForRestructuring
1778000 usd
CY2023Q2 us-gaap Restructuring Reserve
RestructuringReserve
2182000 usd
CY2023Q2 tls Bill Contracts Receivable Net Of Allowance
BillContractsReceivableNetOfAllowance
11815000 usd
CY2022Q4 tls Bill Contracts Receivable Net Of Allowance
BillContractsReceivableNetOfAllowance
13521000 usd
CY2023Q2 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
7214000 usd
CY2022Q4 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
11657000 usd
CY2023Q2 us-gaap Contract With Customer Asset Gross Current
ContractWithCustomerAssetGrossCurrent
15261000 usd
CY2022Q4 us-gaap Contract With Customer Asset Gross Current
ContractWithCustomerAssetGrossCurrent
14891000 usd
CY2023Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
6138000 usd
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
6444000 usd
CY2023Q2 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
1600000 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
4100000 usd
CY2022Q2 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
1600000 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
4100000 usd
CY2023Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
66500000 usd
CY2023Q2 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.80
CY2023Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P12M
CY2023Q2 us-gaap Billed Contract Receivables
BilledContractReceivables
12065000 usd
CY2022Q4 us-gaap Billed Contract Receivables
BilledContractReceivables
13655000 usd
CY2023Q2 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
7214000 usd
CY2023Q2 us-gaap Contract With Customer Asset Gross Current
ContractWithCustomerAssetGrossCurrent
15261000 usd
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
250000 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
134000 usd
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
34290000 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
40069000 usd
CY2023Q2 us-gaap Inventory Gross
InventoryGross
2532000 usd
CY2022Q4 us-gaap Inventory Gross
InventoryGross
3642000 usd
CY2023Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
765000 usd
CY2022Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
765000 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
1767000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
2877000 usd
CY2023Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
19236000 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
19178000 usd
CY2023Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
15394000 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
14391000 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3842000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4787000 usd
CY2023Q2 us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
579000 usd
CY2022Q2 us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
598000 usd
us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
1152000 usd
us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
1157000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
17900000 usd
CY2023Q2 us-gaap Goodwill
Goodwill
17900000 usd
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 usd
CY2023Q2 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 usd
CY2022Q2 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 usd
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
47364000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
9550000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
37814000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
38750000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
8455000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
30295000 usd
CY2023Q2 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
47364000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
9550000 usd
CY2023Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
37814000 usd
CY2022Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
45870000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
8455000 usd
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
37415000 usd
CY2022 us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
600000 usd
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
11985000 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
12606000 usd
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4521000 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
9945000 usd
CY2023Q2 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
16506000 usd
CY2022Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
22551000 usd
CY2023Q2 tls Other Accrued Expenses Current
OtherAccruedExpensesCurrent
725000 usd
CY2022Q4 tls Other Accrued Expenses Current
OtherAccruedExpensesCurrent
1530000 usd
CY2023Q2 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
2182000 usd
CY2022Q4 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
2763000 usd
CY2023Q2 tls Other Current Liabilities Other
OtherCurrentLiabilitiesOther
410000 usd
CY2022Q4 tls Other Current Liabilities Other
OtherCurrentLiabilitiesOther
626000 usd
CY2023Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
3317000 usd
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
4919000 usd
CY2022Q4 tls Debt Instrument Covenant Senior Leverage Ratio Maximum
DebtInstrumentCovenantSeniorLeverageRatioMaximum
3
CY2023Q2 tls Receivables Excluded From Collateral
ReceivablesExcludedFromCollateral
25000000 usd
CY2023Q2 us-gaap Other Income
OtherIncome
0 usd
us-gaap Other Income
OtherIncome
1400000 usd
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
7745000 usd
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
17076000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
17244000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
33007000 usd
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
3906867 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
19.53
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
1604843 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.98
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
1613809 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
26.38
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
457871 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
14.36
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
3440030 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
9.42
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Vested
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested
8800000 usd
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
1.06
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
0
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P0Y
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.035
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.307
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.351
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
0 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P0Y
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
400000 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.80
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
0 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
0
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
400000 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.80
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P9Y9M18D
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
304000000 usd
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
0 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
0
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P0Y
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
0 usd
CY2023Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
400000 usd
CY2022Q2 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
50000000 usd
CY2023Q2 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
38700000 usd
CY2023Q2 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
0 usd
CY2022Q2 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
3002000 usd
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
0 usd
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
3002000 usd
CY2023Q2 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
0 shares
CY2022Q2 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
360439 shares
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
0 shares
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
360439 shares
CY2023Q2 us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
0
CY2022Q2 us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
8.33
us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
0
us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
8.33
CY2023Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
269000 shares
CY2022Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
57000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
401000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
211000 shares
CY2023Q2 tls Incremental Common Shares Excluded From The Dilutive Effect
IncrementalCommonSharesExcludedFromTheDilutiveEffect
265608 shares
tls Incremental Common Shares Excluded From The Dilutive Effect
IncrementalCommonSharesExcludedFromTheDilutiveEffect
265608 shares
CY2022Q2 tls Incremental Common Shares Excluded From The Dilutive Effect
IncrementalCommonSharesExcludedFromTheDilutiveEffect
379161 shares
tls Incremental Common Shares Excluded From The Dilutive Effect
IncrementalCommonSharesExcludedFromTheDilutiveEffect
379161 shares
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 segment
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2 segment
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
32911000 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
55791000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
68133000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
105951000 usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
12359000 usd
CY2022Q2 us-gaap Gross Profit
GrossProfit
20929000 usd
us-gaap Gross Profit
GrossProfit
25841000 usd
us-gaap Gross Profit
GrossProfit
39800000 usd
CY2023Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
21826000 usd
CY2022Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
34965000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
48278000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
70203000 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-9467000 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-14036000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-22437000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-30403000 usd
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1649000 usd
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
118000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
4145000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
130000 usd
CY2023Q2 us-gaap Interest Expense
InterestExpense
184000 usd
CY2022Q2 us-gaap Interest Expense
InterestExpense
187000 usd
us-gaap Interest Expense
InterestExpense
433000 usd
us-gaap Interest Expense
InterestExpense
377000 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-8002000 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-14105000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-18725000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-30650000 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
22000 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
54000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
45000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
125000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-8024000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-14159000 usd
us-gaap Net Income Loss
NetIncomeLoss
-18770000 usd
us-gaap Net Income Loss
NetIncomeLoss
-30775000 usd
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
103447000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
119305000 usd
CY2023Q2 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
134000 usd
CY2022Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
133000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
103581000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
119438000 usd
us-gaap Interest Paid Net
InterestPaidNet
409000 usd
us-gaap Interest Paid Net
InterestPaidNet
353000 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
147000 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
188000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
15000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
282000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
536000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
296000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1943000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 usd
tls Intangible Assets Transferred To Extinguish Other Financing Obligations
IntangibleAssetsTransferredToExtinguishOtherFinancingObligations
7089000 usd
tls Intangible Assets Transferred To Extinguish Other Financing Obligations
IntangibleAssetsTransferredToExtinguishOtherFinancingObligations
0 usd
tls Noncash Common Stock Repurchase Under Srp
NoncashCommonStockRepurchaseUnderSRP
0 usd
tls Noncash Common Stock Repurchase Under Srp
NoncashCommonStockRepurchaseUnderSRP
400000 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
25735000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
50291000 usd
CY2022Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
34965000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
70203000 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-14036000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-30403000 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-14105000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-30650000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-14159000 usd
us-gaap Net Income Loss
NetIncomeLoss
-30775000 usd
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.21
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.45
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.21
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.45
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-14159000 usd
us-gaap Net Income Loss
NetIncomeLoss
-30775000 usd
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-14170000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-30757000 usd

Files In Submission

Name View Source Status
0000320121-23-000046-index-headers.html Edgar Link pending
0000320121-23-000046-index.html Edgar Link pending
0000320121-23-000046.txt Edgar Link pending
0000320121-23-000046-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
formoftelosnoticeofgrantof.htm Edgar Link pending
foroftelosnoticeofgrantofr.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tls-20230630.htm Edgar Link pending
tls-20230630.xsd Edgar Link pending
tls-20230630xexhibit311q223.htm Edgar Link pending
tls-20230630xexhibit312q223.htm Edgar Link pending
tls-20230630xexhibit32q223.htm Edgar Link pending
tls-20230630_g1.jpg Edgar Link pending
tls-20230630_def.xml Edgar Link unprocessable
tls-20230630_pre.xml Edgar Link unprocessable
tls-20230630_htm.xml Edgar Link completed
tls-20230630_cal.xml Edgar Link unprocessable
tls-20230630_lab.xml Edgar Link unprocessable